Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

EGFR, p Tyr1173 Antibody (EM-13), PE/Atto594, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP144893PEATT594

Catalog No. N144893P594


Only null left
Add to Cart

Description

Description

EGFR Monoclonal specifically detects EGFR in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

EGFR
Monoclonal
PE/ATTO 594
PBS with 0.05% Sodium Azide
EGFR
Synthetic phospho-peptide covering sequence around tyrosine 1173 of human EGFR.
0.1 mL
Primary
The antibody EM-13 reacts with human EGFR (ErbB1/ HER1) phosphorylated on tyrosine 1173.
Store at 4°C in the dark. Do not freeze.
Flow Cytometry
EM-13
Flow Cytometry
avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ERBB, ErbB1, ERBB1PIG61, HER1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1
Mouse
Protein A purified
Cancer, Cell Biology, Cell Cycle and Replication, Cellular Markers, Cellular Signaling, Growth and Development, Hypoxia, Phospho Specific, Signal Transduction, Tumor Suppressors, Tyrosine Kinases
1956.0
Human
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.